Section Arrow
DXR.NASDAQ
- Daxor Corp
Quotes are at least 15-min delayed:2026/01/01 04:59 EST
Regular Hours
Last
 14.75
+0.03 (+0.20%)
Day High 
14.75 
Prev. Close
14.72 
1-M High
14.7578 
Volume 
2.37K 
Bid
11.52
Ask
17.31
Day Low
14.368 
Open
14.4412 
1-M Low
12 
Market Cap 
73.37M 
Currency 美元 
P/E 92 
%Yield 0.21 
10-SMA 13.3 
20-SMA 13.04 
50-SMA 13.04 
52-W High 14.7578 
52-W Low 6.55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.16/1.00
Enterprise Value
74.10M
Balance Sheet
Book Value Per Share
7.15
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
2.13M
Operating Revenue Per Share
1.04
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor11.46-0.01-0.09%11.55PE
BAXBaxter International19.11-0.19-0.98%140.32PE
WRBYWarby Parker21.79-0.23-1.04%-- 
EKSOEkso Bionics Holdings Inc8.64-1.94-18.34%-- 
XRAYDENTSPLY SIRONA11.43+0.03+0.26%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.